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Objectives: The objective of this study was to develop methods for evaluating the mechanical 
robustness and estimating the lifetime of the novel bone conduction implant (BCI) that is used 
in a clinical study. The methods are intended to be applicable to any similar device.
Materials and methods: The robustness was evaluated using tests originally developed for 
cochlear implants comprising a random vibration test, a shock test, a pendulum test, and an 
impact test. Furthermore, magnetically induced torque and demagnetization during magnetic 
resonance imaging at 1.5 T were investigated using a dipole electromagnet. To estimate the 
lifetime of the implant, a long-term age-accelerated test was performed.
Results: Out of all the tests, the pendulum and the impact tests had the largest effect on the 
electro-acoustic performance of the BCI implant, even if the change in performance was within 
acceptable limits (<20%). In comparison with baseline data, the lower and higher resonance 
peaks shifted down in frequency by 13% and 18%, respectively, and with a loss in magnitude 
of 1.1 and 2.0 dB, respectively, in these tests.
Conclusion: A complete series of tests were developed, and the BCI passed all the tests; its 
lifetime was estimated to be at least 26 years for patients who are using the implant for 12 
hours on a daily basis.
Keywords: audiology, bone conduction audiometry, electromagnetic transducer, electro-acoustics
Introduction
To rehabilitate patients with conductive or mixed hearing loss, bone conduction devices 
(BCDs) have been successfully used. Based on data gathered in 2015, over 250,000 
patients worldwide are estimated to have been given a percutaneous bone-anchored 
hearing aid (BAHA) since the first implantation in 1977.1 These percutaneous devices 
are classified as passive since only a fixture is implanted in the skull bone. The audio 
processor (AP), including the transducer, is worn externally and attached daily via a 
skin-penetrating abutment in direct contact with the fixture.2 In BCDs, airborne sound 
is picked up by microphones in an externally worn AP that transforms the sound to 
electric signals to drive a vibrating transducer, thus bypassing the outer and middle 
ear. The categorization of a BCD depends on the attachment of the transducer to the 
skull bone.3 In percutaneous BCDs, the transducer is attached with a skin-penetrating 
implant directly to the skull bone, whereas passive and active transcutaneous BCDs 
comprise an implanted unit that is attached to the skull under the intact skin. Depending 
on whether the transducer is comprised in the externally worn AP or in the implanted 
unit, the transcutaneous BCD is said to be either passive or active, respectively.
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In long-term follow-ups, researchers have monitored 
audiometric and surgical outcomes of BAHA patients over 
time. In a study by Tjellström and Granström, follow-up 
data from the first 100 BAHA patients implanted from 1977 
to 1985 were reviewed.4 The cohort series demonstrated 
satisfactory and effective rehabilitation for patients with 
conductive or mixed hearing loss but also noted adverse 
skin reactions. A long-term study by Asma et al reviewed 
follow-up data from 33 patients who had used the BAHA 
for 10 years.5 That study found complications mainly related 
to the skin-penetrating screw, such as adverse skin reactions 
and abutment loss. Implant losses can sometimes occur due 
to trauma to the fixture site or spontaneous extrusion can 
occur due to a lack of osseointegration.6–9
In a clinical investigation of a newer device, called the 
bone conduction implant (BCI), the transducer still transmits 
vibrations directly into the skull bone and is implanted under 
intact skin.10 For this reason, the BCI is categorized as an 
active transcutaneous BCD.3
After numerous preclinical studies,11–14 the first BCI was 
implanted in December 2012; the surgery was straightfor-
ward, safe, and uncomplicated.14 Today, 16 patients with 
conductive or mild-to-moderate mixed hearing loss have been 
implanted. The audiometric measures and patient-related 
outcomes of the first six patients were evaluated in a study 
by Reinfeldt et al,15 where the BCI was found to provide 
either similar or better rehabilitation compared with a BAHA 
on a softband. In a comparative study by Rigato et al,16 the 
BCI was found to provide similar rehabilitation as BAHAs 
in terms of audiometric measures, and the patient-related 
outcomes were improved mainly due to elimination of skin-
related complications.
In the BCI implant, the transducer is positioned in a drilled 
recess in the mastoid part of the temporal bone, and firmly fixed 
and tightened with a titanium wire, keeping the transducer in 
place. This attachment has a flat-surface contact, and thereby 
achieves direct bone conduction (BC) drive.14,17 Figure 1A and 
B illustrates the principal design of an active transcutaneous 
BCD and the external view of the BCI, respectively.
To achieve a long lifetime of the device, the electro-
acoustic performance and audiological outcomes must be 
stable over time, thus relying on the solid condition of the 
implanted part. The goal is that the BCI should function as 
intended for >10 years, but preferably during their whole 
lifetime with no need for maintenance or replacement. The 
average daily usage time for BAHA recipients is up to 12 
hours, and 87% of the BAHA recipients are using the patients 
device for >8 hours a day.18,19 Regarding the BCI, the average 
daily usage time is assumed to be the same as for a BAHA. 
According to a study performed in the USA by Flamme 
et al on 286 subjects, the average daily sound pressure level 
(SPL) exposure during an 8 hour working day is 78 dBA.20 
A similar study has been performed in Sweden by Neitzel 
et al on 45 workers, and the exposure was 73.6 dBA, but 
measured for 24 hours during the day and nighttime.21 It is 
therefore assumed that an implant used in Sweden needs to 
withstand these levels throughout its lifetime.
The implant must withstand not only long-term sound 
exposure but also other environmental factors. After the 
manufacturing process of an implantable medical device has 
been completed, its functionality is verified and documented 
before it is sterilized and implanted. The tests for verification 
of BCDs normally comprise measurements of frequency 
response and total harmonic distortion (THD) using a skull 
simulator.22 These measurements to verify the implant func-
tion cannot be performed once the device has been implanted, 
and the possibilities to objectively measure performance 
become limited. Therefore, the manufacturer must ensure 
that the implant can withstand mechanical hazards that may 
occur after production and throughout its expected lifetime.
Figure 1 The Bone conduction implant system.
Notes: (A) an illustration of the principal design of an active transcutaneous bone conduction device (BcD) showing the audio processor (aP) components, the wireless 
induction link with retention magnets (n=north pole and s=south pole), and the transducer in the bone. The aP unit comprises microphones (Mic), a battery (Bat), a digital 
sound processor (DSP), a power amplifier (PA), and amplitude modulation (AM). (B) External view of the bone conduction implant (Bci).
Audio processor
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In more extreme situations, for example, during sports 
activities or minor accidents, the implant might be subjected 
to more intense mechanical trauma than during normal 
usage conditions, and with the given specifications, it should 
withstand these situations. The requirements and test meth-
ods are commonly set internally by the manufacturer since 
no specific standards and criteria for each type of device 
exist.23 However, the Association for the Advancement of 
Medical Instrumentation (AAMI) has developed a standard 
for cochlear implant (CI) systems,24 and where applicable, 
it may serve as a preliminary guidance for BCDs as well. In 
addition, relevant criteria of maximum acceptable change 
in electro-acoustic performance for a device under testing 
need to be determined.
The titanium wire for securing the implant to the bone can 
be cut for easy removal of the implant in case an explantation 
is needed; for example, during magnetic resonance imaging 
(MRI) of the brain. There are risks related to MRI because 
some parts of the implant comprise magnetic materials that 
can interact with the strong magnetic fields from the MRI 
scanner. In general for hearing implants, MRI may dam-
age the device or induce a loud sound if the implant is not 
removed, and in the worst case, the patient may suffer from 
implant dislocation.25 An image artifact also occurs close to 
the implant, hiding part of the brain image, and for the BCI, 
the artifact covers a range of ~10 cm when performing brain 
imaging in a 1.5 T MRI scanner.26
Even if the BCI should withstand MRI up to 1.5 T, in the 
clinical study, researchers decided that it should be removed 
prior to MRI, since more testing against the American Stan-
dard for Testing Materials (ASTM) is required for the final 
approval of MRI scanning with the implant in place. Torque 
and demagnetization of the retention magnet have also been 
studied separately in Fredén Jansson et al,27 and similar tests 
for the transducer have been performed in this study.
aim of study
The aim of this study was to develop methods and criteria to 
test the robustness and to estimate the lifetime of the BCI for 
ordinary use as well as when subjected to excessive impacts 
and MRI exposure. These test methods will be evaluated 
using the BCI but are expected to be applicable to similar 
devices.
Methods and materials
Bci transducer
The BCI transducer is based on the balanced electromag-
netic separation transducer (BEST) principle, which is 
 comprehensively described in a study by Håkansson.28 
Initially, the BEST principle was developed to make BC 
transducers small and robust enough for implantation under 
the skin and as powerful as the variable reluctance type trans-
ducers used in conventional BAHAs. It offers new features 
such as low distortion, which is also beneficial in other BC 
applications. One such application is the new audiometric 
bone conduction vibrator Radioear B81, which is used for 
BC audiometry to assess the degree of sensorineural hearing 
loss.29 In comparison with the variable reluctance type of 
transducer, the BEST principle transducer has four air gaps 
instead of one. The forces in those air gaps are balanced, 
which results in a cancellation of quadratic nonlinear forces 
as well as static forces and establishes a favorable dynamic 
force-to-size relation.
Mechanical testing
The mechanical testing in this study comprised a random 
vibration test, a shock test, a pendulum test, and an impact 
test, all proposed by and included in AAMI.24 An age-accel-
erated test of the electro-acoustic performance of the implant 
was performed to estimate its lifetime. The magnetically 
induced torque of the BCI transducer during 1.5 T MRI was 
investigated using a dipole electromagnet GMW 5403 (GMW 
Associates, Inc., San Carlos, CA, USA) and in accordance 
with ASTM standard F2213. In addition, the performance 
of the transducer was compared before and after 15 minutes 
exposure to the static magnetic field of the electromagnet in 
the same position as when scanned in patients.
In total, the testing used four randomly selected sample 
implants with the transducer capsulated in titanium and sealed 
with silicone (Figure 1B) in all but one side (the side attached 
to the skull bone): one for the mechanical robustness tests, 
two for the MRI tests, and one for the age-accelerated test. 
In the mechanical tests, the same transducer was used in a 
sequence of tests, which means that it inherits a history from 
every test done. This history might affect the performance in 
the upcoming tests, but if one sample implant withstands the 
sequence of all required testing, it is assumed to withstand 
each one of those tests.
In addition to vibrations during normal usage, the trans-
ducer may be exposed to vibrations during manufacturing, 
sterilization, and transport from the manufacturer to the 
surgery room. The implant’s robustness to such vibrations 
is tested using a random vibration noise with a wide fre-
quency spectrum and with a power spectral density of 0.7 
(m/s2)2/Hz from 5 to 805 Hz applied for 30 minutes in three 
orthogonal directions (see Figure 2A for the directions). An 
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impedance head, model B&K8001 (Brüel and Kjaer, Nærum, 
Denmark), was used to monitor the accelerations, and an 
adapter made it possible to position the implant in the three 
orthogonal directions on a Minishaker B&K4810 (Brüel and 
Kjaer; Figure 2B). The Minishaker was driven via an LPA01 
Laboratory Power Amplifier (Newtons4th Ltd., Leicester, 
UK) and the random vibration pattern was generated by an 
Agilent signal analyzer 35670A (Agilent Technologies Inc., 
Santa Clara, CA, USA). 
The mechanical shock test (Figure 2C) simulates small 
shocks that might occur to the implant due to rough handling 
or accidental trauma. A half-sine-shaped acceleration pulse 
A with a target severity of 500 g over 1 ms was applied to the 
transducer in five directions (Figure 2A) in the mechanical 
shock test. The surface where the feedthroughs are positioned 
on the transducer (direction x, not shown in Figure 2A) was 
not tested because the receiver coil will be connected to the 
feedthroughs in the complete design, which will protect that 
surface from any  mechanical exposure. An aluminum rod gen-
erated the pulse with an implant holder attached on the lower 
end of a rod via a soft and compliant dampening material that 
mechanically isolates the implant holder from any vibrations 
induced in the rod. Attached to the rigid implant holder is the 
implant as well as an accelerometer to monitor the pulse shape 
as the implant holder hits a wall. The peak value of the pulse is 
controlled by releasing the rod from a certain height h.
The pendulum test (Figure 2D) is not standardized, but 
was designed to simulate a fall from 50 cm onto a stiff sur-
face if the implant is, for example, accidentally dropped on 
a sterile metallic table. It is assumed to be similar to a free 
fall from the same height, since the pendulum has low fric-
tion and low air resistance. Instead of letting the implant fall 
freely onto a surface from 50 cm, the surface material falls 
and hits the implant from a height of 50 cm, but moves in the 
pendulum direction at impact (Figure 2D) before it is caught 
in a soft container. The pendulum motion allows for each side 
of the implant to be tested in a controlled manner and avoids 
random effects from rebouncing strikes. However, this test 
is not designed to simulate a free fall onto a floor, which is 
typically softer than aluminum and therefore less challenging. 
Similar to the mechanical shock test, the pendulum test is 
also done in all five directions (Figure 2A), but exerts a faster 
Figure 2 The Mechanical Tests.
Notes: (A) The striking directions used in the mechanical shock test and the pendulum test. (B) The setup for the random vibration test showing how to attach the 
transducer on a fixture in order to vibrate it in three orthogonal directions, showing the mounting of the transducer for vertical testing. (C) The setup for the mechanical 
shock test showing how the shock pulse a with an amplitude of 500 g and duration of 1 ms was applied to the implant. a compliant dampening material kept the implant in 
the device holder mechanically isolated from an aluminum rod being released from a height h into a wooden wall. (D) The setup for the pendulum or fall test showing how 
to strike the implant in order to simulate an accidental drop from height h. The implant rests on a flat surface and the aluminum rod is dropped from height h in a controlled 
motion giving a fixed collision velocity v. (E) The setup for the mechanical impact test showing how to apply the energy E of 2.5 J by dropping a spherical object of mass m 
from height h onto the implant as it rests on a solid and rigid surface, covered by a silicone sheet that represents the skin.
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and larger pulse with acceleration peaks of >1,000 g. This 
test is therefore considered a worst case scenario, where the 
impact is much more demanding for the implant to withstand 
as compared to the mechanical shock test.
To test how well the transducer withstands mechanical 
compression toward external impacts to the head (eg, from 
trauma or other external forces), the transducer was exposed 
to an impact of 2.5 J in a so-called impact test (Figure 2E). In 
this test, the implant rested on a firm and solid non-resilient 
surface to emulate how it would be positioned in a drilled 
recess in the skull bone when implanted in a patient. Only 
one surface, facing out from the skull bone, can be exposed 
to external impacts and needs to be tested (see direction z 
in Figure 2A). To apply the mechanical impact, a spherical 
metal weight of 1.622 kg was dropped from a height of 15.7 
cm onto the implant. In a study by Raine et al,30 the skin 
flap thickness of the CI patients reaches about 5 mm after 
6 months, which is assumed to be similar in most active 
transcutaneous BCD patients. To represent a relatively thin 
skin thickness as a worst case scenario, a 3 mm silicone sheet 
covered the test surface, while the opposite side faced a rigid 
and solid material to represent the cranial surface of the skull 
bone. The time signal and acceleration spectral density of 
the random vibration test pattern are shown in Figure 3A 
and B, respectively, and the half-sine-shaped acceleration in 
the mechanical shock test with a pulse A over ~1 ms with 
an average peak value of 529±38 g is shown in Figure 3C.
lifetime estimation
To estimate the lifetime of the BCI implant, one sample is 
kept inside a chamber where it is continuously exposed to 
sound; as of February 2019, it had been tested for 45 months 
(Figure 4). Its functionality has been verified once a month 
by measuring its electro-acoustic performance. To include 
the effect of the body temperature under the skin, where 
the implant is positioned in patients, the ambient target 
temperature inside the chamber is 37±1°C, achieved by a 
heat-radiating light bulb. The temperature has been measured 
once a month and adjusted if needed. The sound source was 
chosen to be the Swedish radio channel program 1 comprising 
a mixture of both speech and music. This test is still running 
and will continue until the device fails.
Figure 3 Mechanical exposure of the random vibration and the shock test.
Notes: (A) The time signal and (B) the acceleration spectral density of the same noise as applied in the random vibration test. (C) The average shape of the 500 g pulses 
over 1 ms that were applied to the five striking directions in the mechanical shock test.
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The goal is that the BCI should function at least 10 years. 
To estimate the lifetime of the implant, the “use” can be accel-
erated by increasing the daily equivalent continuous sound 
level (LEQ), estimated to be 73.6 dBA by Neitzel et al,21 and 
increasing the daily time patients use the implant, assumed 
to be on average 12 hours, both at home and during work.18,19 
Therefore, the average LEQ value in the box was increased 
from 73.6 to 78.6 dBA, and the exposure time from 12 to 24 
hours continuously. These increases mean an approximately 
two times higher sound level (5 dB) than the normal sound 
exposure, which corresponds to 3.6 times increase in power 
or energy exposure, and a factor of 2 given by the increased 
exposure time from 12 to 24 hours. In total this means that 
the aging of the implant in the sound chamber is estimated to 
be accelerated by a total factor of ~7 times. The LEQ value 
and the temperature were measured once a month to ensure 
they maintained the desired values.
In comparison with the random vibration test, where the 
exposure to externally imposed vibration is evaluated, the 
long-term sound exposure test for lifetime estimation evalu-
ates how the transducer is affected by its own vibrations.
MRi testing
A dipole electromagnet GMW 5403 (GMW Associates, Inc.) 
was used to investigate the effect on the transducer of a static 
magnetic field inside an MRI scanner (see the measurement 
setup in Figure 5A and B). The transducer was placed in 
a gap between two coils, where the dipole electromagnet 
generated a homogenous static magnetic field of 1.5 T. The 
static magnetically induced torque was measured at different 
angles (α) using a force gauge and an angle meter with the 
transducer mounted on a nonmagnetic rod that could freely 
rotate inside the field with low friction. In one test, the trans-
ducer was rotated 360 degrees, and the magnetically induced 
torque was measured every 10 degrees. In the other test, the 
transducer was kept in the magnetic field for 15 minutes at 
a position where α=0, similar to how it is positioned in a 
patient being examined in an MRI scanner.
Frequency response measurements
The electro-acoustic performance of the transducer was 
measured before and after all testing by using either an 
acoustic (Figure 6A) or an electric (Figure 6B) input. In the 
Figure 4 The external view of the age-acceleration sound chamber used in the long-term sound exposure test of the implant. The chamber includes the bone conduction 
implant attached to the skull simulator, a speaker playing the swedish radio channel P1 at 79.8 dBa, a microphone, a heat source, and a temperature sensor.
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lifetime estimation experiment and the MRI tests, an acoustic 
frequency response was measured to detect possible damage 
to the implant. In the acoustic frequency response measure-
ment, the complete BCI was excited by a speaker inside an 
anechoic test chamber, B&K 4222 (Brüel and Kjaer). Both 
the output force level and the THD were measured for fre-
quencies between 100 and 10,000 Hz on a skull simulator 
using SoundCheck software (Varst Technology A/S, Højberg, 
Denmark) to control the measurement (Figure 6A).22 The 
input at the BCI AP microphone was kept at two constant 
SPLs of either 70 or 90 dB. At 70 dB SPL, the THD was 
measured, and at 90 dB SPL, the AP was saturated, thus giv-
ing the maximum power output (MPO) capacity of the BCI 
system not influenced by gain settings; at saturation THD is 
quite meaningless.
In the electric frequency response measurements for 
frequencies from 100 to 10,000 Hz, a constant input voltage 
was generated by an Agilent 33220A Function/Arbitrary 
Waveform Generator and controlled by an Agilent 35670A 
FFT Dynamic Signal Analyzer (Agilent Technologies Inc.). 
Data were collected using the software LabVIEW (National 
Instruments Corporation, Austin, TX, USA) via a universal 
serial bus interface. This measurement was done through-
out the mechanical robustness and age-accelerated lifetime 
tests to compare with baseline data. The advantage with the 
electric frequency measurement is that the performance of 
Figure 5 setup for magnetically induced torque measurements.
Notes: (A) The mounting of the transducer inside the dipole electromagnet relative to the north and south poles where the magnetic field is uniform (1.5 T). (B) The 
transducer is fixed inside a cylindrical rod that can rotate with low friction, and a force gauge is connected to a disc on the rod to enable torque measurements. At one end 
an angle meter is positioned.
TransducerTransducer
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axis support
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Figure 6 setup for acoustic and electric measurements.
Notes: (A) Electro-acoustic measurement setup for output force level and total harmonic distortion (ThD) of the full bone conduction implant (Bci) system. The implant 
and audio processor are attached to the skull simulator inside the anechoic test chamber B&K 4222, where a speaker generates a constant sound pressure level from 100 
to 10,000 Hz. A microphone connected to a power supply (mic power supply) and high pass filter amplifier (HPF & 20 dB gain) verifies the sound pressure level, and a 
laptop reads the output signal from the skull simulator. The measurement is monitored and controlled using soundcheck software (Varst Technology) through a soundcard 
interface. (B) setup for the electric frequency response measurements of the implant, from 100 to 10,000 hz, using a skull simulator, an agilent 35670a FFT Dynamic signal 
analyzer, and an agilent 33220a Function/arbitrary Waveform generator (agilent Technologies). The measurement was recorded using labViEW software via a universal 
serial bus (UsB) interface.
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the implant is measured without acoustical influence. If the 
AP fails over time, it can easily be replaced or have its audio 
settings adjusted, but replacing the implant requires surgery; 
the implant must therefore withstand higher demands.
criteria
The criteria for maximum acceptable change in the electro-
acoustic performance of a BCD could be based on either 
frequency response measurements, not affected by the set-
tings in the AP, or the MPO when the AP is saturated. If the 
criteria are based on MPO measurements, compression and 
automatic functions should be disabled in the AP settings 
to avoid uncertainty if the maximum output was reached 
or not. The criteria can be specified in terms of maximum 
acceptable frequency shifting of the resonance peak(s) and/
or loss in magnitude of the frequency response or in the 
MPO. Comparing the two measurement methods, MPO is a 
measurement of the whole system, that is, both the AP and 
the implant, while the frequency response excludes the AP 
and is a measurement of the implant alone. If the goal is to 
investigate only the implanted unit, the frequency response 
is the more reliable measurement. This measurement tech-
nique is especially important for long-term measurements, 
such as the age-accelerated test, because the AP can always 
be replaced if it fails to function. In other words, if a change 
is observed in the MPO curve, it is possible to know if the 
change is related to the condition of the AP or the implant 
by also measuring the frequency response.
The general goal of the performance acceptance criteria 
is to make sure that the device offers sufficient hearing reha-
bilitation for indicated patients and that any change in the 
electro-acoustic performance due to mechanical exposure is 
negligible or can be adjusted for in the AP settings without 
reaching saturation or generating too much distortion. Yet no 
standardized test methods are developed for active transcu-
taneous BCDs to investigate the mechanical robustness and 
specific requirements to withstand. Instead, manufacturers 
use their own standards to assure proper function for intended 
use. The stress levels used in these tests are meant to be 
representative for all active transcutaneous BCDs and based 
on assumed maximum exposure levels; that is, they are not 
excessively high or unrealistically low. As long as realistic 
maximum exposure levels are applied during the tests, the 
manufacturers can formulate and motivate their criteria for 
maximum acceptable change in performance of the implant.
We recommend formulating the criteria to meet the 
output requirements of a fully functioning device based on 
objective measurable parameters, such as frequency response 
 measurements. In a study by Taghavi et al,10 the frequency 
response of the BCI was specified to have a low-frequency 
resonance peak around 800 Hz (640–960 Hz) and a high 
resonance peak around 4,500 Hz (3,600–5,400 Hz). In terms 
of production variability, a maximum acceptable deviation in 
the frequency response is set to ±20% for the resonance fre-
quency peaks and a 5 dB loss in the magnitude at the middle 
frequencies, around 2 kHz. Therefore, the same criteria as 
for maximum acceptable production variability is used as 
criteria for mechanical robustness for the BCI in this study.
Results
Mechanical testing
There was no observed effect on the transducer frequency 
response after the random vibration test and mechanical 
shock test in comparison with the baseline measurement 
(Figure 7A and B, respectively).
In the pendulum test, the transducer was struck in five 
orthogonal directions from a height of 50 cm, which resulted 
in a change of the frequency response. The low-frequency 
resonance peak shifted from 832 to 724 Hz (13%) and 
decreased 1.1 dB in amplitude, and the high-frequency peak 
shifted from 5,492 to 5,012 Hz (9%) and decreased 4.1 dB 
(Figure 7C). Each direction was tested in ascending order 
from direction 1 to 5 (Figure 2A), and small increments were 
observed after each direction, but it was not until the fourth 
striking direction that the maximum change was reached.
The impact test of 2.5 J did not have any negative effect on 
the low-frequency resonance peak, while the high-frequency 
peak increased 2.1 dB in amplitude and shifted from 5,012 
to 4,571 Hz (9%; Figure 7D).
lifetime estimation
The average value of the monthly measured temperature 
and LEQ-value in the test chamber were 37.8±0.8°C and 
78.6±4.5 dBA, respectively. Figure 8A shows the frequency 
responses of the transducer after the age-accelerating test in 
comparison with baseline measurement at the start, verifying 
a stable and unaffected implant performance over time. The 
transducer and AP combined were also verified to function 
normally after the age-accelerating test, by measurements of 
the MPO at 90 dB SPL and THD at 70 dB SPL (Figure 8B).
At the time of writing (February 2019), the implant had 
been operating inside the age-accelerating test chamber 
without any significant change in performance for over 45 
months. With an accelerated aging factor of seven times, 
these 45 months correspond to a 26-year period of usage for 
patients who are using the device for 12 hours on a daily basis. 
In other words, this BCI is estimated to have an expected 
lifetime of >26 years.
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Figure 7 The frequency response with electric input of 1 Vpeak to the transducer before (solid line) and after (dashed line) (A) the random vibration test, (B) the mechanical 
shock test, (C) the pendulum test, and (D) the 2.5 J impact test.
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(gray area) in comparison with baseline (solid line).
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MRi testing
The magnetically induced torque acting on the BCI trans-
ducer followed a sinusoidal function with a maximum 
amplitude of 0.135 Nm as seen in Figure 9A. A ±90 degree 
angle shift occurred every 90 degrees due to the interaction 
between the applied magnetic field and the induced magnetic 
field in the soft iron material of the transducer. Therefore, the 
torque first had to be measured counterclockwise and then 
clockwise, or vice versa, in order to measure one full lap 
from 0 to 360 degrees, as shown in Figure 9A.
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When the transducer was exposed to the static magnetic 
field of 1.5 T for 15 minutes, both the MPO at 90 dB SPL 
and THD at 70 dB SPL were unaffected (Figure 9B).
Discussion
A series of tests to evaluate robustness has been developed 
and used on the BCI system. These tests may also be applied 
to other active transcutaneous BCD. However, relevant 
criteria of maximum acceptable change in electro-acoustic 
performance need to be determined for each individual 
type of device, which was not addressed in this study. For 
example, these tests do not apply for the transducers in 
BAHA processors, which are worn externally and therefore 
expose higher risks to mechanical trauma. On the other hand, 
if a BAHA processor is damaged, it can easily be replaced 
without surgery.
The mechanical tests were performed in a certain order, 
with the random vibration test first, followed by the shock 
test, as these two tests were assumed to be the least harmful. 
These tests had no observed effect on the electro-acoustic 
performance and was followed by the pendulum test to 
simulate a drop from 50 cm onto a stiff metallic surface. The 
pendulum test caused a more noticeable effect on transducer 
performance even though the frequency response remained 
within the criteria. This change was considered minor and 
can easily be compensated for by increasing the gain in the 
AP settings without reaching saturation or generating high 
distortion. Regarding the relevance of the pendulum test, if an 
unsealed implant was accidently dropped on the floor before 
or during surgery, it would be contaminated and should not be 
implanted. However, if the unsealed implant was accidentally 
dropped on a sterilized table or roughly handled, it could still 
be implanted. The pendulum test is therefore limited to 50 cm 
and should assure that the implant is designed to withstand the 
scenario of being dropped on a sterile table, typically made 
of metal where draping of the table is not accounted for. In 
comparison with the mechanical shock test, the pendulum 
test is almost identical, except that the pendulum test exerts 
a faster and larger pulse and is therefore considered much 
more severe than the mechanical shock test. Therefore, if 
the implant withstands the pendulum test, there is no need 
to perform the mechanical shock test.
Once in place, the implant is no longer at risk of being 
dropped, but it can still be exposed to external impacts and 
smaller shocks, and it needs to withstand vibrations, both 
externally imposed and internally generated by the transducer 
itself during normal use. To test the ability of transducers to 
withstand external impacts, the mechanical impact test was 
performed. Remarkably, no major effect was observed in 
electro-acoustic performance even though the same trans-
ducer had been used in the sequence of all mechanical tests.
The age-accelerating test tested the implant for approxi-
mately two times longer and at four times higher sound power 
(~5 dB higher amplitude level) than a BCI in normal use. 
These conditions give an estimated accelerated aging factor 
of 7; thus at present, after 45 months of testing, the estimated 
lifetime of an implant is at least 26 years of normal use. This 
estimation is based on one sample BCI that was picked from 
the backup implants remaining after implantation surgery in 
all 16 patients in the clinical study. All these implants were 
very similar, had passed all quality assurance tests, and were 
approved for implantation. The test implant was picked at 
Figure 9 Results from the MRi testing.
Notes: (A) The magnetically induced torque of the transducer when it was rotated 360 degrees inside the static magnetic field of the dipole electromagnet. (B) Maximum 
power output (MPO) at 90 dB sound pressure level (sPl) of the transducer at baseline (dashed line) and after the magnetic resonance imaging (MRi) test (solid line), and total 
harmonic distortion (ThD) at 70 dB sPl (gray area) in comparison with baseline (solid line).
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random. Patients’ lifestyle may be another factor that can 
affect the lifetime of the implants other than long periods of 
sound exposure, body temperature, and high sound levels. 
This effect is difficult to include in the age-accelerating test, 
since it varies among individuals and is hard to predict, but as 
the device has passed through all mechanical tests, it should 
resist such exposures with safe margins.
Because the patient might need an MRI, the implant’s 
robustness related to MRI must be evaluated as well. From 
previous studies about the MRI safety of the BCI implant, 
the magnetically induced torque caused by the retention 
magnet in the receiver coil is ~0.40 Nm during 1.5 T MRI.31 
In comparison with the maximum induced torque on the trans-
ducer, which is 0.135 Nm, the retention magnet is concluded 
to be the main contributor to magnetically induced torque. 
The observed effects on the electro-acoustic performance 
are in line with the findings in Fredén Jansson et al,26 where 
the BCI was scanned in a 1.5 T MRI scanner. However, the 
torque of the retention magnet and that of the transducer are 
not assumed to constructively interact as their magnetiza-
tion directions in relation to the static magnetic field of the 
MRI scanner are different. For this reason, the torques of the 
transducer and retention magnet cannot simply be added to 
determine the total torque of the whole implant in a worst 
case scenario. This study found that the peak torque on the 
transducer occurred at a deflection angle perpendicular to the 
peak torque from the retention magnet, which means that the 
torque of the transducer is zero when the torque of the reten-
tion magnet is maximum and vice versa. This indicates that 
the worst case scenario torque of the whole implant equals 
the maximum torque on the retention magnet, because it is 
higher than the maximum torque of the transducer. Even if 
the BCI passed these pilot tests of 1.5 T MRI, additional tests 
are needed for the device to be approved for MRI in a patient. 
Also, it is common to use MRI scanners with higher static 
magnetic field strengths, such as 3 T. This will have a signifi-
cantly stronger impact on an implanted unit than 1.5T, which 
need to be tested in a separate study. Among all tests in this 
study, the ones relevant for evaluating the postsurgical robust-
ness of the implant are the MRI test, mechanical shock test, 
random vibration, and long-term sound exposure, while the 
pendulum test is more relevant for the presurgical robustness.
Regarding the non-accelerated usage time in actual 
patients, it has been ~6 years since the first patient received 
a BCI implant. Based on the measurement of patient-related 
outcomes and audiometric results, no implant deterioration 
has been observed in that patient and none of the 16 patients, 
who to date have an accumulated usage time of 58 years, have 
reported serious adverse events.
Conclusion
The BCI was tested using a series of mechanical tests com-
prising a random vibration test, a shock test, a pendulum test, 
and an impact test. In addition, MRI compatibility of the BCI 
was tested in a static magnetic field of 1.5 T under normal 
scanning conditions. Finally, the lifetime of one implant was 
estimated under accelerated aging conditions.
The criteria proposed for the BCI to be considered fully 
functional are as follows: 1) the change in resonance peaks 
should not be >±20% in frequency, and 2) the magnitude 
should not deteriorate >5 dB for the middle frequencies, 
typically measured around 2 kHz.
The BCI withstood the static magnetic field of 1.5 T, 
fulfilled the robustness criteria in all mechanical tests, and 
had a lifetime estimated to be >26 years for patients using 
the device for 12 hours on a daily basis.
The same testing can be applied to evaluate other similar 
active transcutaneous BCDs designed with the transducer 
directly attached to the skull bone under intact skin and pro-
vided that appropriate criteria are set for the specific device.
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